Publications by authors named "Steve Rowland"

Claim this Profile
G
Global Medical Device Clinical Trials Involving Both the United States and Japan: Key Considerations for Development, Regulatory Approval, and Conduct.
Shin Iwamoto, Kenneth Cavanaugh, Misti Malone, Aaron Lottes, Robert Thatcher, Steve Rowland

Cardiovasc Revasc Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Distinguishing Groundwater Influenced by Oil Sands Process-Affected Water (OSPW) from Natural Bitumen-Influenced Groundwaters.
L Mark Hewitt, James W Roy, Steve J Rowland, Greg Bickerton, Amila DeSilva

Environ Sci Technol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake, Whole-Body Distribution, and Depuration of Nanoplastics by the Scallop Pecten maximus at Environmentally Realistic Concentrations.
Maya Al-Sid-Cheikh, Steve J Rowland, Karen Stevenson, Claude Rouleau, Theodore B Henry

Environ Sci Technol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing spatial and temporal variability of acid-extractable organics in oil sands process-affected waters.
Richard A Frank, Craig B Milestone, Steve J Rowland, John V Headley, Richard J Kavanagh

Chemosphere· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling oil sands mixtures from industrial developments and natural groundwaters for source identification.
Richard A Frank, James W Roy, Greg Bickerton, Steve J Rowland, John V Headley

Environ Sci Technol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Comment on "Profiling oil sands mixtures from industrial developments and natural groundwaters for source identification".
Richard A Frank, James W Roy, Greg Bickerton, Steve J Rowland, John V Headley

Environ Sci Technol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microplastic moves pollutants and additives to worms, reducing functions linked to health and biodiversity.
Mark Anthony Browne, Stewart J Niven, Tamara S Galloway, Steve J Rowland, Richard C Thompson

Curr Biol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model.
Katarína Larsen, Caroline Cheng, Dennie Tempel, Sherry Parker, Saami Yazdani, Steve Rowland

Eur Heart J· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor.
Jason D Burch, Julie Farand, John Colucci, Claudio Sturino, Yves Ducharme, Steve Rowland

Bioorg Med Chem Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of potent and selective EP(4) receptor ligands: facile modulation of agonism and antagonism.
Michael J Boyd, Carl Berthelette, Jean-François Chiasson, Patsy Clark, John Colucci, Steve Rowland

Bioorg Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix.
Juan F Granada, Shigenobu Inami, Michael S Aboodi, Armando Tellez, Krzysztof Milewski, Steve Rowland

Circ Cardiovasc Interv· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain.
John Colucci, Michael Boyd, Carl Berthelette, Jean-Francois Chiasson, Zhaoyin Wang, Steve Rowland

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.
Marc Blouin, Yongxin Han, Jason Burch, Julie Farand, Christophe Mellon, Steve Rowland

J Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a homogeneous immunoassay for the detection of angiotensin I in plasma using AlphaLISA acceptor beads technology.
Elizabeth Cauchon, Susana Liu, M David Percival, Steve E Rowland, Daigen Xu

Anal Biochem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
Jason D Burch, Michel Belley, Réjean Fortin, Denis Deschênes, Mario Girard, Steve Rowland

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis.
Anne-Marie Pulichino, Steve Rowland, Tom Wu, Patsy Clark, Daigen Xu

J Pharmacol Exp Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis